Microbiome-Independent Effects of Antibiotics in a Murine Model of Nosocomial Infections.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
28 06 2022
Historique:
pubmed: 26 5 2022
medline: 1 7 2022
entrez: 25 5 2022
Statut: ppublish

Résumé

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of hospital-acquired pneumonia. To better manage patients with MRSA pneumonia, we require a greater understanding of the host-pathogen interactions during infection. MRSA research focuses on highly virulent and cytotoxic strains, which demonstrate robust phenotypes in animal models of infection. However, nosocomial infections are often caused by hospital-acquired MRSA (HA-MRSA) isolates that exhibit low cytotoxicity and few or no phenotypes in mice, thereby confounding mechanistic studies of pathogenesis. Consequently, virulence pathways utilized by HA-MRSA in nosocomial pneumonia are largely unknown. Here, we report that conditioning mice with broad-spectrum antibiotics lowers the barrier to pneumonia, thereby transforming otherwise avirulent HA-MRSA isolates into lethal pathogens. HA-MRSA isolates are avirulent in gnotobiotic mice, mimicking results in conventional animals. Thus, the observed enhanced susceptibility to infection in antibiotic-treated mice is not due to depletion of the microbiota. More generally, we found that antibiotic conditioning leads to increased susceptibility to infection by diverse antimicrobial-resistant (AMR) pathogens of low virulence. Treatment with antibiotics leads to dehydration and malnutrition, suggesting a potential role for these clinically relevant and reducible hospital complications in susceptibility to pathogens. In sum, the model described here mitigates the impact of low virulence in immunocompetent mice, providing a convenient model to gain fundamental insight into the pathogenesis of nosocomial pathogens.

Identifiants

pubmed: 35612285
doi: 10.1128/mbio.01240-22
pmc: PMC9239109
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0124022

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI099394
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140754
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI105129
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121244
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI149350
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137336
Pays : United States

Références

Nature. 2013 Jan 3;493(7430):51-5
pubmed: 23235831
Infect Immun. 2014 Nov;82(11):4889-98
pubmed: 25183728
Methods Enzymol. 1991;204:587-636
pubmed: 1658572
Nat Med. 2007 Dec;13(12):1405-6
pubmed: 18064027
Dis Mon. 1987 Dec;33(12):681-780
pubmed: 3319464
Nat Med. 2010 Feb;16(2):228-31
pubmed: 20081863
EMBO Rep. 2016 Mar;17(3):428-40
pubmed: 26882549
J Clin Invest. 2009 Jul;119(7):1931-9
pubmed: 19603548
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
J Infect Dis. 2012 Oct;206(8):1168-77
pubmed: 22859823
Am J Pathol. 2011 Jul;179(1):199-210
pubmed: 21703402
Mucosal Immunol. 2010 Mar;3(2):148-58
pubmed: 19940845
Nature. 1983 Oct 20-26;305(5936):709-12
pubmed: 6226876
Diagn Microbiol Infect Dis. 2017 Aug;88(4):342-347
pubmed: 28529090
J Infect Dis. 2015 Jun 15;211(12):1862-74
pubmed: 25298028
Ann Intern Med. 1981 Nov;95(5):549-55
pubmed: 7294544
Elife. 2021 May 04;10:
pubmed: 33944776
J Pathol Bacteriol. 1950 Oct;62(4):541-54
pubmed: 14804233
Nature. 2014 Dec 4;516(7529):94-8
pubmed: 25409145
Mol Med. 2011 Mar-Apr;17(3-4):293-307
pubmed: 21046059
J Immunol. 2005 Sep 15;175(6):3907-19
pubmed: 16148137
J Hosp Infect. 2013 Jun;84(2):143-50
pubmed: 23602415
mBio. 2017 Oct 24;8(5):
pubmed: 29066545
Clin Exp Immunol. 2009 Aug;157(2):216-24
pubmed: 19604261
Chem Rev. 2011 Jan 12;111(1):117-51
pubmed: 21174435
Mol Microbiol. 2012 Jan;83(2):423-35
pubmed: 22142035
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
J Infect Dis. 2008 Oct 15;198(8):1166-70
pubmed: 18729780
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
J Surg Res. 2008 Dec;150(2):278-85
pubmed: 18621398
Curr Opin Microbiol. 2018 Feb;41:43-50
pubmed: 29197673
Oncologist. 2012;17(10):1329-36
pubmed: 22707509
Annu Rev Genet. 2008;42:541-64
pubmed: 18713030
PeerJ. 2019 May 31;7:e6995
pubmed: 31183253
Front Microbiol. 2018 Aug 22;9:1901
pubmed: 30186248
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S378-85
pubmed: 18462093
Mol Microbiol. 2011 Feb;79(3):814-25
pubmed: 21255120
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6333-40
pubmed: 27527081
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32602902
ILAR J. 2015;56(2):169-78
pubmed: 26323627
Cell Host Microbe. 2015 Sep 9;18(3):363-70
pubmed: 26320997
Nat Rev Microbiol. 2017 Jul;15(7):435-447
pubmed: 28420883
Mol Microbiol. 2014 Aug;93(4):664-81
pubmed: 24962815
J Infect Dis. 2017 May 1;215(9):1386-1395
pubmed: 27638942
Nat Med. 2018 Jan 9;24(1):10-19
pubmed: 29315295
PLoS One. 2011 Mar 21;6(3):e17996
pubmed: 21445311
Microbiome. 2021 Feb 1;9(1):37
pubmed: 33522966
Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S15-S28
pubmed: 28196877
Cell. 2004 Jul 23;118(2):229-41
pubmed: 15260992
Sci Immunol. 2020 Mar 27;5(45):
pubmed: 32220976
Infect Immun. 2014 Nov;82(11):4596-606
pubmed: 25135683
J Exp Med. 2008 Feb 18;205(2):287-94
pubmed: 18268041
Microbiology (Reading). 2008 Aug;154(Pt 8):2265-2274
pubmed: 18667559
mBio. 2019 Jan 2;10(1):
pubmed: 30602580
Blood Rev. 1995 Sep;9(3):183-90
pubmed: 8563520
Lancet. 2006 Mar 4;367(9512):731-9
pubmed: 16517273
Clin Infect Dis. 2012 Mar 1;54(5):621-9
pubmed: 22247123
Nat Med. 2004 Aug;10(8):842-8
pubmed: 15247912
Cell Rep. 2019 Oct 29;29(5):1074-1081.e5
pubmed: 31665625
Bioinformatics. 2020 Jun 1;36(12):3882-3884
pubmed: 32311023
J Infect Dis. 2008 Apr 15;197(8):1079-81
pubmed: 18419525
Microbes Infect. 2012 Apr;14(4):380-6
pubmed: 22178792
Infect Immun. 2011 May;79(5):1927-35
pubmed: 21402769
Mol Microbiol. 2015 Apr;96(2):388-404
pubmed: 25612137
Cell Host Microbe. 2013 May 15;13(5):584-594
pubmed: 23684309
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18091-6
pubmed: 22025717
PLoS Negl Trop Dis. 2017 Apr 19;11(4):e0005548
pubmed: 28422970
Cell Host Microbe. 2013 Oct 16;14(4):453-9
pubmed: 24139401
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
J Infect Dis. 2010 Nov 15;202(10):1593-9
pubmed: 20942648
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5883-8
pubmed: 19293374
J Infect Dis. 2008 Oct 15;198(8):1171-4
pubmed: 18752431
Trends Microbiol. 2013 May;21(5):221-9
pubmed: 23454077
Gut. 2016 Apr;65(4):575-83
pubmed: 26511795
Microbiol Mol Biol Rev. 2014 Jun;78(2):199-230
pubmed: 24847020
Infect Immun. 2007 Feb;75(2):1040-4
pubmed: 17101657

Auteurs

Keenan A Lacey (KA)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.

Sandra Gonzalez (S)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.

Frank Yeung (F)

Kimmel Center for Biology and Medicine at the Skirball Institute, New York University Grossman School of Medicine, New York, New York, USA.

Gregory Putzel (G)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA.

Magdalena Podkowik (M)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Medicine, Division of Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA.
Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA.

Alejandro Pironti (A)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA.

Bo Shopsin (B)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Medicine, Division of Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA.
Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA.

Ken Cadwell (K)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Kimmel Center for Biology and Medicine at the Skirball Institute, New York University Grossman School of Medicine, New York, New York, USA.
Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA.
Division of Gastroenterology and Hepatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.

Victor J Torres (VJ)

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH